Area of research
Infectious Diseases · Epidemiology
Research interest
Research focused on Incidence (geometry) and Intensive care medicine, with related work in Aspergillosis, Intensive care unit, Fungal disease. Notable publications include 'Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of...', 'Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1', and 'Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease'.
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study
Damping excessive viral-induced IFN-γ rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis
Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis
Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading
A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue
High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation
C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1
A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
Polymorphous adenocarcinoma of the salivary glands: reappraisal and update